| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/24/1993 | EP0211894B1 Fsh |
| 03/21/1993 | CA2078358A1 Multivalent hepatitis b virus vaccine |
| 03/18/1993 | WO1993005147A1 Defective interfering hiv particles with chimeric cd4-env |
| 03/18/1993 | WO1993004678A1 Antimicrobial preservation of platelets and blood factors |
| 03/17/1993 | EP0531728A1 HSV gD2 Baculovirus expression system |
| 03/17/1993 | EP0321489B1 Molecular cloning and clones of human b lymphotropic virus (hblv) |
| 03/16/1993 | US5194595 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 03/16/1993 | US5194381 Plasmids and DNA coding for proteins |
| 03/14/1993 | CA2078087A1 Hsv gd2 baculovirus expression system |
| 03/09/1993 | US5192539 Infectious bursal disease virus production in continuous cell lines |
| 03/04/1993 | WO1993003760A1 Sirs vaccine and diagnosis method |
| 03/04/1993 | WO1993003759A1 Papua new guinea human t-lymphotropic virus |
| 03/03/1993 | EP0529584A2 Viral agent associated with the Mystery Swine Disease |
| 03/03/1993 | EP0529493A2 Methods and reagents for hepatitis C detection |
| 03/03/1993 | EP0529160A1 Gene protein products and methods of cell therapy |
| 03/03/1993 | EP0318498B1 Human b lymphotropic virus (hblv) isolation and products |
| 03/02/1993 | US5190880 Tube known as straw, for cryogenically preserving biological samples |
| 02/27/1993 | CA2616717A1 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
| 02/27/1993 | CA2076903A1 Recombinant fowlpox virus |
| 02/24/1993 | EP0527839A1 Recombinant library screening methods |
| 02/24/1993 | EP0527786A1 Purified hcv and hcv proteins and peptides |
| 02/24/1993 | EP0527771A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 02/18/1993 | WO1993003173A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
| 02/18/1993 | WO1993003144A1 Viral vector-based insecticides and expression systems |
| 02/18/1993 | CA2111116A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
| 02/17/1993 | CN1069068A Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus |
| 02/16/1993 | US5187090 For tumor diagnosis |
| 02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
| 02/16/1993 | US5186933 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
| 02/10/1993 | EP0396563B1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 02/09/1993 | US5185440 cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof |
| 02/09/1993 | US5185146 Recombinant mva vaccinia virus |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002104A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | WO1993001833A1 Improved vaccine |
| 02/04/1993 | CA2113641A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | CA2113572A1 Improved vaccine |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183658 A pathogen of hemorrhagic fever with renal syndrome; strain from human body is injected to one-day old mouse, raised to ten days, paralyzing and cutting head apart of rat to take brain, purification, inactivation and addition of adjuvant |
| 01/28/1993 | DE4124522A1 In-vitro cultivation of human papilloma virus - using kerato-acanthoma replicating the virus as starting cell line with cultivation over at least four weeks |
| 01/26/1993 | US5182210 Fowlpox virus promoters |
| 01/26/1993 | CA1313151C Vaccine against rinderpest virus using recombinant vaccinia virus |
| 01/21/1993 | WO1993001279A1 Recombinant hepatitis a virus vaccine |
| 01/21/1993 | WO1993001278A1 Feline lymphoid cell lines capable of producing fiv |
| 01/21/1993 | WO1993001276A1 Continuous cell line and vaccine against avian coccidia |
| 01/21/1993 | WO1993001273A1 Screening method for chronic fatigue syndrome |
| 01/20/1993 | EP0523406A1 Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity |
| 01/20/1993 | EP0523140A1 Reagents and methods for modulating gene expression through rna mimicry |
| 01/19/1993 | US5180675 Recombinant fowlpox virus |
| 01/19/1993 | US5180581 Nuclear Polyhedrosis Virus |
| 01/13/1993 | EP0522482A2 Coccidiosis vaccines |
| 01/13/1993 | EP0522291A1 Process for purifying hepatitis a virus (HAV), virus thus purified and vaccine compositions containing it |
| 01/13/1993 | EP0233937B1 Fermentation methods for hepatitis vaccine production |
| 01/13/1993 | CA2073588A1 Coccidiosis vaccines |
| 01/12/1993 | US5178094 Method and apparatus for mass producing insects entomopathogens and entomoparasites |
| 01/12/1993 | CA1312546C Preparation of retrovirus-free immunoglobulins |
| 01/07/1993 | WO1993000442A1 De novo cell-free synthesis of picornavirus |
| 01/07/1993 | WO1993000365A2 Hepatitis c virus (hcv) polypeptides |
| 01/07/1993 | WO1993000103A1 Chimeric envelope proteins for viral targeting |
| 01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
| 01/07/1993 | EP0521427A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 01/07/1993 | CA2115991A1 De novo cell-free synthesis of picornavirus |
| 01/06/1993 | CA2073085A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening inhibitors of human cytomegalovirus |
| 12/30/1992 | EP0520753A1 Recombinant fowlpox vaccine for protection against Marek's disease |
| 12/29/1992 | US5174993 Immunology |
| 12/23/1992 | WO1992022641A1 Immunodeficiency virus recombinant poxvirus vaccine |
| 12/23/1992 | WO1992022577A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 12/23/1992 | WO1992022198A1 Method and apparatus for mass producing insects entomopathogens and entomoparasites |
| 12/23/1992 | WO1992015605A3 Inhibitors of human neutrophil elastase and human cathepsin g |
| 12/23/1992 | EP0519901A2 Virus-inactivated blood product |
| 12/23/1992 | EP0262192B1 Method and means for producing a protein having the same igg specificity as protein g |
| 12/23/1992 | CA2111235A1 Method and apparatus for mass producing insects entomopathogens and entomoparasites |
| 12/23/1992 | CA2110489A1 Immunodeficiency virus recombinant poxvirus vaccine |
| 12/22/1992 | US5173414 Production of recombinant adeno-associated virus vectors |
| 12/22/1992 | US5173400 Antibody detection of antibodies to viral proteins in serum |
| 12/19/1992 | CA2070903A1 Process for purifying hepatitis a virus (hav), virus thus purified and vaccine compositions containing it |
| 12/16/1992 | EP0518757A1 Peptides or polypeptides of BVD and related viruses |
| 12/16/1992 | EP0518756A1 Procedure to detect a bovine viral diarrhoea virus infection, nucleotide sequence coding for a protein induced by infection with this virus and recombinant proteins and antigens resulting from same |
| 12/16/1992 | EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 12/16/1992 | EP0517859A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 12/16/1992 | EP0517792A1 Terminally blocked antiviral peptides |
| 12/15/1992 | US5171677 Recombinant marek's disease virus and process for preparing the same |
| 12/12/1992 | CA2071015A1 Immunogenic peptides or polypeptides of the bvd virus and related viruses, vaccines incorporating them or expressing them, methods and means of production thereof |
| 12/10/1992 | WO1992021751A1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 12/10/1992 | WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 12/10/1992 | DE4118155A1 Acid-stable mutants of human rhinovirus serotype 14 - used for treatment of rhino-viral infection obtd. by incubating wild type virus at varying pH cycles |
| 12/09/1992 | EP0517292A1 Recombinant Avipox virus |
| 12/08/1992 | US5169784 Baculovirus dual promoter expression vector |
| 12/08/1992 | US5169753 Reacting human serum with fractionated proteins from retrovirus, then assaying for serum antibody binding to selected retroviral proteins |
| 12/07/1992 | WO1992021375A1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 12/02/1992 | EP0516287A2 Human rotavirus of serotype 3 HCR3A, reassortants thereof and vaccine compositions containing them |
| 12/01/1992 | CA1310924C Infective drug delivery system |
| 11/28/1992 | CA2069594A1 Recombinant avipox virus, culture of cells infected by this virus and fowl vaccines derived therefrom |
| 11/26/1992 | WO1992020787A1 Stealth virus detection in the chronic fatigue syndrome |
| 11/26/1992 | WO1992020786A1 Hepatitis a virus production |
| 11/26/1992 | WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 11/26/1992 | CA2109603A1 Stealth virus detection in the chronic fatigue syndrome |
| 11/25/1992 | EP0514603A1 Viral mediated destruction of neoplastic cells |
| 11/24/1992 | US5166057 Templates for gene expression |
| 11/19/1992 | EP0514199A2 Vaccines and methods for their production |